Lack of Disease Specificity Limits the Usefulness of In Vitro Costimulation in HIV- and HCV-Infected Patients

Table 1

Clinical characteristics of study subjects. Data are given as means  ±  SD, unless otherwise specified. HCV: hepatitis C virus; HIV: human immunodeficiency virus; ALT: alanine aminotransferase; N/A: not applicable.

	HCV	HIV	Healthy
Gender	𝑛=10 males	𝑛=4 males	𝑛=4 males
		𝑛=6 females	𝑛=2 females
Age	52.75±2.3	34.8±5.9	29.6±3.4
CD4 cell count, 10^6 cells/L	N/A	451.3±134.9	N/A
Plasma HIV RNA level, IU/mL	0.0±0.0	8,685.1±15,122.8	0.0±0.0
HCV genotype	Type 1: 𝑛=9	N/A	N/A
	Type 2: 𝑛=1
Plasma HCV RNA level, IU/mL	1,699,275±1,505,121	0.0±0.0	0.0±0.0
Albumin, g/dL	3.9±0.5	N/A	N/A
ALT, IU/L	80.3±67.2	N/A	N/A
Total bilirubin level, mg/dL	0.5±0.3	N/A	N/A
Platelet count, 10^3 cells/mm^3	211.6±55.8	N/A	N/A
On treatment	4/10	8/10	0/10